Table 2

Results at end of study for patients treated by paediatrician or asthma nurse*

Mean (SD)PaediatricianAsthma nurseMean (95% CI) differencep value
*Results are presented as mean (SD) or median (range).
†Patients ⩾5 years of age performed lung function measurements (n=31 in paediatrician group, n=24 in asthma nurse group).
‡Number per patient per year.
§Number of days per year for patients ⩾4 years of age.
¶Median daily dose of fluticasone during the study.
FEV1 (%pred)†103.0 (11.5)101.4 (15.0)1.6 (−5.5 to 8.7)0.65
log10 PD202.5 (0.5)2.4 (0.6)0.1 (−0.2 to 0.3)0.63
Symptom-free days (%)70.5 (24.2)68.0 (22.5)2.5 (−8.8 to 13.8)0.54
Rescue medication-free days (%)76.8 (28.6)75.8 (20.9)1.0 (−11.1 to 13.2)0.40
Median (range) Median (95% CI) difference
Fluticasone (µg)¶200 (0–636)200 (0–500)0 (−49.0 to 24.1)0.75
Exacerbations‡0 (0–2.0)0 (0–2.0)0 (0 to 0)0.37
Visits to GP‡0 (0–3.0)0 (0–3.0)0 (0 to 0)0.11
School absence§0 (0–21.0)0 (0–23.0)0 (0 to 0)0.80
Daytime symptom score0.4 (0–1.4)0.4 (0–1.2)0.01 (−0.2 to 0.2)0.83
Night time symptom score0.3 (0–1.2)0.3 (0–1.4)0.1 (−0.2 to 0.1)0.24